课题基金 / 基金详情

FGF-23 REGULATION OF PHOSPHATE HOMEOSTASIS

FGF-23 REGULATION OF PHOSPHATE HOMEOSTASIS
FGF-23 磷酸盐稳态的调节
批准号:
6692972
负责人:
KENNETH E WHITE
金额:
$23.18万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-12-27 至 2007-11-30

项目摘要

项目成果

KENNETH E WHITE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The regulation of serum phosphate concentrations is a complex process and our current models are far from complete. We positionally cloned a novel gene from chromosome 12p13.3, FGF23, that encodes a secreted factor, and demonstrated that, when mutated, the gene is responsible for the renal phosphate wasting disorder autosomal dominant hypophosphatemic rickets (ADHR). We also determined that FGF-23 is overexpressed in tumors causing oncogenic hypophosphatemic osteomalacia (OHO), and in vivo evidence supports the role of FGF-23 as a phosphaturic substance. The cellular and molecular mechanisms by which FGF-23 causes isolated renal phosphate wasting are currently unknown, however. The long-term goals of the present studies are to understand the molecular physiology and function of genes involved in regulating renal phosphate reabsorption controlled by FGF-23. The study of the phosphate-wasting metabolic syndromes, ADHR and OHO, provides a unique opportunity to discover novel pathways controlling renal phosphate homeostasis. Currently there are no animal models for ADHR, thus limiting the ability to test hypotheses regarding the physiological mechanisms underlying the disease. The hypothesis to be tested within this proposal is: FGF-23 acts through a specific receptor to cause changes in gene transcription and translation in kidney proximal tubule that result in decreased renal absorption of phosphorous. We will test this hypothesis through the following Specific Aims: (1) to test for changes in the expression of renal and skeletal genes in mice that may be regulated by FGF-23 in vivo; (2) to determine the FGF receptor(s) involved in FGF-23 actions on the kidney proximal tubule; and (3) to develop an appropriate mouse model of ADHR and to understand the manifestations of the disorder. The results of the proposed studies will provide insight into the pathogenesis of ADHR and OHO, as well as lead to improved understanding of the mechanisms dictating phosphate homeostasis in the long-term.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Therapy for Hyperphosphatemic Familial Tumoral Calcinosis (hfTC) and Generalized Hyperphosphatemia
  • 批准号:
    10818072
  • 项目类别:
  • 资助金额:
    $30.19万
  • 财政年份:
    2023
  • 负责人:
    KENNETH E WHITE
  • 依托单位:
Targeting sKlotho-FGF23 Interactions to Improve Pathological Phosphate Handling in CKD
Targeting sKlotho-FGF23 Interactions to Improve Pathological Phosphate Handling in CKD
Targeting sKlotho-FGF23 Interactions to Improve Pathological Phosphate Handling in CKD
国内基金
海外基金
沉默Zdhhc23基因降低mTOR 蛋白棕榈酰化抑制黑色素瘤增殖的机制研究
  • 批准号:
    JCZRLH202601126
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
  • 批准号:
    JCZRLH202600588
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
肠道菌群-代谢物-miR-23a轴在结直肠癌发生发展的作用机制及临床应用研究
DUSP23通过抑制Trim21泛素化酶活性调控GPX4和铁死亡在脑缺血再灌注损伤中的机制研究
  • 批准号:
    JCZRLH202601660
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: